About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Houston | 131 Studies

Clinical Trials SchizophreniaHouston

Schizophrenia Clinical Trials in Houston

Find 131 clinical trials for schizophrenia near Houston, Texas. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 131 trials

CompletedStudy of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive DyskinesiaThis study will evaluate the effectiveness of valbenazine on patient- and clinician-reported outcomes assessing health-related quality of life, functioning, and treatment effect…NCT05859698·Bryant, Arkansas and 17 others CompletedComparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With SchizophreniaKey objectives of this clinical study are to: * Determine how well intramuscular (IM) olanzapine depot works compared to placebo * Evaluate the safety and tolerability of IM…NCT00088478·National City, California and 36 others

Schizophrenia Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedLurasidone Low-Dose - High-Dose Study StudyThe primary purpose of this study is to evaluate the efficacy of lurasidone 20 mg/day in subjects with an acute exacerbation of schizophrenia.NCT01821378·Little Rock, Arkansas and 65 others

CompletedA Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized PatientsThe purpose of this study is to compare the efficacy and safety of ziprasidone and aripiprazole in hospitalized patients with schizophrenia or schizoaffective disorderNCT00634348·Anaheim, California and 40 others

TerminatedStudy to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With SchizophreniaStudy to evaluate the safety and efficacy of luvadaxistat compared with placebo on improving cognitive performance in participants with schizophrenia.NCT05182476·Phoenix, Arizona and 48 others

CompletedImmediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With SchizophreniaThe purpose of this study is to determine that the efficacy of the sustained release (SR) formulation of quetiapine (Seroquel) is not inferior to the immediate release (IR)…NCT00206128·Birmingham, Alabama and 68 others

UnknownDIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using AripiprazoleThis is a 12 month, pragmatic trial designed to assess the differences in a digital medicine system (DMS)- ABILIFY MYCITE (Aripiprazole tablets with sensor)- measuring adherence…NCT03881449·Durham, North Carolina and 1 other

CompletedA Study of ALKS 3831 in Adults With SchizophreniaThis is a Phase 2, randomized, placebo-controlled multicenter study, which will be conducted in 2 parts.NCT01903837·Little Rock, Arkansas and 60 others

CompletedProof of Concept Study of Cognitive Improvement in Patients With SchizophreniaThe purpose of this study is to demonstrate that AZD3480 improves cognition in patients with stable schizophrenia who are being treated with an atypical antipsychotic and who are…NCT00528905·Little Rock, Arkansas and 79 others

TerminatedA Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic FeaturesApproximately 450 patients will be randomized to receive mifepristone or placebo for 7 days followed by antidepressant.NCT00637494·Little Rock, Arkansas and 41 others

CompletedA Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of SchizophreniaThis study is open to people aged 18 years or older with schizophrenia. People can join the study if they are willing to use a smartphone app called CT-155.NCT06791122·Imperial, California and 30 others

CompletedOpen Label Extension Study of BifeprunoxA one year extension study using flexible doses, 20 or 30 mg daily, of open-label bifeprunox.NCT00366171·Little Rock, Arkansas and 82 others

CompletedPediatric Bipolar RegistryThe goal of the Pediatric Bipolar Registry (PBR) is to provide a comprehensive assessment regarding the diagnosis and treatment of pediatric bipolar disorder to children and…NCT02360267·Houston, Texas

CompletedStudy of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic DisordersStudy to learn if the alternate formulation is effective in agitated schizophrenic patientsNCT00036127·Anaheim, California and 15 others

CompletedA Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)This study will evaluate weight gain of ALKS 3831 compared to olanzapine in adult subjects with schizophrenia.NCT02694328·Little Rock, Arkansas and 53 others

CompletedOlanzapine Treated Adolescents With Schizophrenia or Bipolar I DisorderThe purpose of this study is to characterize olanzapine pharmacokinetics: the inter- and intra- subject variabilities of olanzapine pharmacokinetics; and the potential influence…NCT00113594·Cerritos, California and 16 others

CompletedOpen-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With SchizophreniaThe phase 3 Trial 31-12-291 is part of the aripiprazole IM depot clinical development program and has been designed to demonstrate the efficacy and safety of aripiprazole IM depot…NCT01683058·Little Rock, Arkansas and 37 others

Terminated20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative SymptomsThe purpose of this study is to evaluate the effect of AMG 747 on negative symptoms of schizophrenia in patients who are stable on current antipsychotic treatment.NCT01568216·Anaheim, California and 37 others

CompletedA Comparator Study of LY2140023 Versus Placebo in Schizophrenia PatientsAn inpatient/outpatient study to see if LY2140023 is better than placebo in acutely ill patients with schizophrenia.NCT01086748·Escondido, California and 27 others

CompletedSafety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of SchizophreniaThis study is to determine the efficacy (how well the drug works), safety, and side effects of the study medication compared to placebo in the treatment of the negative symptoms…NCT00063297·Birmingham, Alabama and 28 others

Page 1 of 7Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia